Strata Critical Medical, Inc. Class A Common Stock SRTA Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $222.83M+16.1% | $191.91M-14.8% | $225.18M+54.1% | $146.12M+118% | ||
| $174.76M+14.3% | $152.89M-16.5% | $183.06M+47.8% | $123.85M+128% | ||
| $48.07M+23.2% | $39.02M-7.4% | $42.12M+89.1% | $22.28M+73.3% | ||
| 21.6%+1.2pp | 20.3%+1.6pp | 18.7%+3.5pp | 15.2%-3.9pp | ||
| —— | $50.86M— | —— | —— | ||
| $6.9M+448% | $1.26M-82.3% | $7.11M+24.2% | $5.73M+388% | ||
| —— | $52.11M— | —— | —— | ||
| —— | $52.11M— | —— | —— | ||
| -$22.67M+35.3% | -$35.01M+48.6% | -$68.12M-27.3% | -$53.53M-65.9% | ||
| -10.2%+8.1pp | -18.2%+12.0pp | -30.3%+6.4pp | -36.6%+11.4pp | ||
| $4.24M-41.2% | $7.21M-14.5% | $8.44M— | —— | ||
| $2.29M— | —— | $10.58M-58.5% | $25.5M+403% | ||
| -$20.38M+28.9% | -$28.65M+50.2% | -$57.54M-105% | -$28.03M+35.8% | ||
| $21K+166% | -$32K+97.8% | -$1.47M-89.9% | -$772K— | ||
| —— | -$27.31M+51.3% | -$56.08M-43.4% | -$39.11M-5.9% | ||
| -$20,066,000.00— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | -$0.36+53.2% | -$0.77-92.5% | -$0.40+46.7% | ||
| —— | -$0.36+53.2% | -$0.77-97.4% | -$0.39+48.0% | ||
| 325.7M+5.4% | 308.9M+3.1% | 299.7M+2.6% | 292M+30.1% | ||
| 325.7M+5.4% | 308.9M+5.5% | 292.8M+2.9% | 284.5M+31.5% | ||
| —— | $0— | —— | —— | ||
| $4.24M-41.2% | $7.21M-14.5% | $8.44M— | —— | ||
| -$0.24— | —— | —— | —— | ||
| -$0.24— | —— | —— | —— | ||
| —— | $1.26M— | —— | —— | ||
| -$20.07M— | —— | —— | —— | ||
| $222.83M+16.1% | $191.91M-14.8% | $225.18M+54.1% | $146.12M+118% | ||
| -$22.67M+35.3% | -$35.01M+48.6% | -$68.12M-27.3% | -$53.53M-65.9% | ||
| -$14.48M+50.2% | -$29.05M+52.4% | -$61.01M-27.6% | -$47.8M-53.8% | ||
| -$14.48M+50.2% | -$29.05M+52.4% | -$61.01M-27.6% | -$47.8M-53.8% | ||
| -6.5%+8.6pp | -15.1%+12.0pp | -27.1%+5.6pp | -32.7%+13.6pp | ||
| -$22.67M+35.3% | -$35.01M+48.6% | -$68.12M-27.3% | -$53.53M-65.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Strata Critical Medical, Inc. Class A Common Stock's revenue?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated $254.3M in revenue over the trailing twelve months, up 44.2% year over year.
- Is Strata Critical Medical, Inc. Class A Common Stock profitable?
- Strata Critical Medical, Inc. Class A Common Stock reported $52.3M in net income over the trailing twelve months, a 21.0% net margin.
- What are Strata Critical Medical, Inc. Class A Common Stock's profit margins?
- Gross margin is 21.7% and operating margin is -7.8%, with a 21.0% net margin.
- What is Strata Critical Medical, Inc. Class A Common Stock's earnings per share?
- Strata Critical Medical, Inc. Class A Common Stock's diluted EPS over the trailing twelve months is $0.64.
- Where does Strata Critical Medical, Inc. Class A Common Stock's income statement data come from?
- Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
